CW April 2003
Volume 12Issue Number 4 April 2003 ISSN 10593802 Angiogenic Inhibitor in Combination with Chemotherapy for Colorectal CancerA monoclonal antibody directed against a growth factor that helps the growth of new blood vessels at the tumor site seems to boost the effects of standard chemotherapeutic agents in the treatment of metastatic colorectal cancer.
Go to Previous Page Go to Next Page Source & Additional Reading F. Kabbinavar et al., Journal of Clinical Oncology, January 2003. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW April 2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
